Physician profile
William R Cooper
NPI 1124127147
$1,501.66
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,240 · 2020: $123 · 2022: $139.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $403.16 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $139.04 | 2022 | |
| Genentech USA, INC. | $138.28 | 2019 | |
| Mallinckrodt Enterprises LLC | $124.39 | 2019 | |
| Glaxosmithkline, LLC. | $114.42 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $102.37 | 2019-2020 | |
| Advanced Respiratory, INC | $66.04 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.76 | 2019 | |
| Pfizer INC. | $43.31 | 2019 | |
| Philips North America LLC | $39.60 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $39.37 | 2019 | |
| Mylan Specialty L.P. | $23.18 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $23.17 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $22.03 | 2019 | |
| Grifols USA, LLC | $21.96 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $19.24 | 2019 | |
| Shire North American Group INC | $18.73 | 2019 | |
| Arbor Pharmaceuticals, INC. | $18.57 | 2019 | |
| Resmed Corp | $18.14 | 2019 | |
| Boston Scientific Corporation | $15.94 | 2019 | |
| Jazz Pharmaceuticals INC. | $14.69 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.51 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.44 | 2020 | |
| Insmed, INC. | $11.34 | 2019 | |
| Circassia INC. | $10.98 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.